Summary

Mold-Tek Packaging Ltd has reported a surge in pharma sales by 5 times and a 12.10% increase in sales for the 9 months ended on December 31, 2025. The EBDITA for the period increased by 19.83% and the net profit increased by 17.95%. The company's Board of Directors approved the unaudited financial results for the quarter and nine months ended on December 31, 2025.

Key Highlights

1. 1

   Pharma Sales and volume grew 5 times during the 9 months

2. 2

   Sales Increased by 12.10% 9Mon9M

3. 3

   Sales Volume increased by 9.37% 9M on 9M

4. 4

   EBDITA for the period increased by 19.83% 9M on 9M

5. 5

   Net Profit increased by 17.95% 9M on 9M

6. 6

   Revenue from operations increased

7. 7

   Other income increased

8. 8

   Cost of materials consumed decreased

9. 9

   Employee benefits expense increased

10. 10

    Finance costs decreased

11. 11

    Depreciation and amortization expenses decreased

12. 12

    Exceptional items decreased

13. 13

    Profit before tax increased

14. 14

    Deferred tax increased

15. 15

    Profit for the period increased

16. 16

    Total Comprehensive Income for the period increased